Oruka Therapeutics, Inc.$15.23 %
Analyst Rating: Hold
Stock Details
CEO
Lawrence Otto Klein
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
28
Address
221 Crescent Street Building 23, Suite 105, Menlo Park, MA
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Oruka Therapeutics, Inc. $15.23
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results